PGNX - Progenics Pharmaceuticals, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4144
Avg. Estimate-0.22-0.19-0.94-0.74
Low Estimate-0.46-0.19-1.23-0.97
High Estimate-0.09-0.19-0.74-0.49
Year Ago EPS-0.17-0.22-0.87-0.94
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts4144
Avg. Estimate12.86M8.5M33.19M44.86M
Low Estimate4.37M8.5M26.12M32.44M
High Estimate17.57M8.5M37.3M64M
Year Ago Sales3.24M4.15M15.62M33.19M
Sales Growth (year/est)297.20%104.80%112.50%35.20%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.11-0.19-0.19-0.24
EPS Actual-0.17-0.22-0.23-0.22
Difference-0.06-0.03-0.040.02
Surprise %-54.50%-15.80%-21.10%8.30%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.22-0.19-0.94-0.74
7 Days Ago-0.22-0.19-0.94-0.74
30 Days Ago-0.22-0.19-0.94-0.74
60 Days Ago-0.22-0.19-0.94-0.74
90 Days Ago-0.18-0.19-0.88-0.59
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesPGNXIndustrySectorS&P 500
Current Qtr.-29.40%N/AN/A0.02
Next Qtr.13.60%N/AN/A0.06
Current Year-8.00%N/AN/A-0.03
Next Year21.30%N/AN/A0.14
Next 5 Years (per annum)296.40%N/AN/A0.07
Past 5 Years (per annum)-16.22%N/AN/AN/A